Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
India · Delayed Price · Currency is INR 419.30
+8.55 (2.08%)
Sep 24, 2026, 11:10 AM IST
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 53.37 billion as of September 23, 2026. Its market cap has increased by 19.43% in one year.
Market Cap
53.37B
Enterprise Value
54.93B
Revenue
1.74B
Ranking
n/a
PE Ratio
109.62
Stock Price
419.30
ChartMarket Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 53.37B, an increase of 153,258.74%. That is a compound annual growth rate of 34.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 53.37B | 10.70% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Strides Pharma Science | 113.84B |
| Aarti Pharmalabs | 76.76B |
| Innova Captab | 68.57B |
| Sun Pharma Advanced Research Company | 63.64B |
| Orchid Pharma | 54.87B |
| RPG Life Sciences | 45.65B |
| Solara Active Pharma Sciences | 36.34B |
| Ind-Swift Laboratories | 32.99B |